PPAR compounds

   
   

PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.

Activadores de la alfa de PPAR, composiciones farmacéuticas que contienen tales compuestos y el uso de tales compuestos de elevar ciertos niveles de lípido del plasma, incluyendo el lipoprotein-cholesterol de alta densidad y de bajar ciertos otros niveles de lípido del plasma, tales como LDL-colesterol y triglycerides y de tratar por consiguiente las enfermedades que son exacerbadas por los niveles bajos del colesterol de HDL y/o los altos niveles del LDL-colesterol y de los triglycerides, tales como atherosclerosis y enfermedades cardiovasculares, en mamíferos, incluyendo seres humanos.

 
Web www.patentalert.com

< Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

< Ester compound and medicinal use thereof

> Modulators of peroxisome proliferator activated receptors (ppar)

> Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same

~ 00171